TPST · Tempest Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Matthew Angel CEO and President | ▲ Buy | Open Market | 231,482 Shares held | 3/24/2026 | View profile |
| Versant Venture Capital VI, L.P. 10% Owner | ▼ Sell | Open Market | 209,941 Shares held | 8/12/2024 | View profile |
| Stephen R. Brady President and CEO | ▲ Buy | Open Market | 46,376 Shares held | 7/3/2024 | View profile |
| Justin Trojanowski Corporate Controller | ▲ Buy | Open Market | 22,168 Shares held | 6/28/2024 | View profile |
| Samuel Whiting Chief Medical Officer | ▲ Buy | Open Market | 9,573 Shares held | 7/2/2024 | View profile |
Transaction History
| Matthew Angel | ▲ Buy | Open Market | 231,482 | $500K | 3/24/2026 |
| Matthew Angel | ▲ Buy | Open Market | 231,482 | $500K | 3/24/2026 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 387,999 | $427K | 8/12/2024 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 400,000 | $540K | 8/8/2024 |
| Stephen R. Brady | ▲ Buy | Open Market | 35,000 | $74K | 7/3/2024 |
| Samuel Whiting | ▲ Buy | Open Market | 4,672 | $10K | 7/2/2024 |
| Justin Trojanowski | ▲ Buy | Open Market | 7,500 | $16K | 6/28/2024 |